为解决 Gustilo IIIA 和 IIIB 型胫骨骨折保肢与截肢决策难题，乌干达研究人员开展 GHOISS 评分预测准确性研究。结果显示 GHOISS 评分 13 时预测效果最佳。推荐阅读，助您了解该评分在骨折治疗决策中的重要价值。 在医疗领域，骨折问题一直是个备受关注的话题 ...

Researchers recently validated the ninth edition of the TNM staging system for SCLC, finding improved accuracy and predictive ...

RELAX is a phase IIIb, multicenter, randomized, double-blind, placebo-controlled clinical trial designed to evaluate the long-lasting efficacy and satisfaction of RelabotulinumtoxinA in 132 adults ...

A Delta Junction woman received three years of probation for pointing a high-powered laser at military helicopters, injuring ...

A woman in Delta Junction was sentenced on Thursday for pointing a high-powered laser at two military helicopters — ...

Joining a clinical trial for cervical cancer opens the door to new treatments that could have life-changing effects.

肺癌是我国及世界范围内发病率和死亡率最高的恶性肿瘤之一，非小细胞肺癌（NSCLC）约占肺癌的 85%，1/3 的患者在确诊时已为局部晚期 NSCLC，5 年生存率仅 13% ~ 16%。其中，N2 期肺癌患者预后更差，手术切除后 3 年生存率仅 9% ...

A Delta Junction woman received three years of probation Thursday morning for pointing a laser at two Canadian Armed Forces ...

研究人员在研究过程中用到了几个关键技术方法。他们从患者身上收集了术后石蜡包埋（FFPE）的肿瘤组织和肿瘤引流淋巴结样本，制作成组织微阵列（TMA）。然后，利用多重免疫组织化学（mIHC）技术，给样本中的细胞 “贴上标签”，识别出不同类型的细胞。接着，通过图像分析软件对扫描后的样本图像进行处理，计算细胞密度和细胞间的相互作用。最后，运用统计学方法对数据进行分析，找出有意义的结果。

优时比（UCB）跻身全球TOP 20 生物制药公司之列，成为新上榜企业。其市值实现翻倍，从 2023 年的 169 亿美元增至 2024 年的 387 亿美元。数据来源：GlobalData, Pharma Intelligence Center; Stock Exchanges; Annual Reports。版权归环球数据所有。

【小哪吒配音演员揭秘：每根头发丝都叛逆 ...

Organoids were cultured from healthy donor iPSC sources and differentiated using the human iPSC-derived Cerebral Organoid ...